Chrissy Copponex, APRN
Chrissy Copponex, APRN
Program: Blood and Marrow Transplant and Cellular Immunotherapy
Language(s): English
-
Overview
FNP-C, APRN, is an advanced practice professional in Tampa Bay, Florida who specializes in malignant hematology, bone marrow transplant, and cellular immunotherapy. At Moffitt Cancer Center, she cares for patients facing complex blood cancers and solid tumor malignancies, including multiple myeloma, Non-Hodgkin lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, malignant melanoma, and patients undergoing experimental cellular therapy.
Chrissy has extensive experience in advanced treatment approaches such as autologous and allogeneic bone marrow transplant, CAR-T cell therapy, T-cell receptor (TCR) therapy, and tumor-infiltrating lymphocyte (TIL) therapy. She is committed to helping patients and families understand their treatment options and feel supported throughout every phase of care.
She began her career as a bedside nurse in malignant hematology before becoming a nurse practitioner in 2014. Chrissy earned her Bachelor of Science in Nursing from Emory University and her Master of Science in Nursing, with Family Nurse Practitioner certification, from Augusta University. Her clinical practice has focused primarily on bone marrow transplant and cellular immunotherapy.
Chrissy’s dedication to patient care has been recognized through multiple honors, including March of Dimes Nurse of the Year Finalist (2012), DAISY Award recipient (2016), and Moffitt Cancer Center APP of the Year nominee (2023, 2024). She is an active member of the American Society of Transplant and Cellular Therapy and the American Association of Nurse Practitioners.
Compassionate, knowledgeable, and deeply committed to her patients, Chrissy strives to provide exceptional, evidence-based care for individuals seeking advanced treatment for
-
Publications
- Logue JM, Peres LC, Hashmi H, Colin-Leitzinger C, Shrewsbury AM, Hosoya H, Gonzalez R, Copponex C, Kottra KH, Hovanky V, Sahaf B, Patil S, Lazaryan A, Jain MD, Baluch A, Klinkova O, Bejanyan N, Faramand RG, Elmariah H, Khimani F, Davila ML, Mishra A, Blue B, Grajales-Cruz AF, Castaneda Puglianini O, Liu H, Nishihori T, Freeman CL, Brayer J, Shain KH, Baz R, Locke FL, Alsina M, Sidana S, Hansen DK. Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma. Blood Adv. 2022 Dec.6(24):6109-6119. Pubmedid: 35939783. Pmcid: PMC9768247.
-
Patient Comments
1 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Learn more about our patient satisfaction surveyComments
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
Learn more about our patient comments
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
Learn more about our patient satisfaction survey, ratings and comments